-
2012
Company Description
Calibrium is an emerging privately held biopharmaceutical company.
Calibrium is an emerging privately held biopharmaceutical company focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases. Calibrium was co-founded by Fritz French, Calibrium’s Chief Executive Officer, and Richard DiMarchi, PhD, Calibirum’s Chief Scientific Officer.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Company Website:
-
Company E-mail:
-
Company Address:
11711 N. Meridian Street, Suite 300Carmel, INUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits